JPMorgan Chase & Co. Lowers Gentex (NASDAQ:GNTX) Price Target to $27.00

JPMorgan Chase & Co. has reduced its price target for Gentex (NASDAQ:GNTX) to $27.00 from $28.00, while maintaining a "neutral" rating. This new target implies a potential upside of 13.23% from the stock's previous close. Despite beating EPS expectations with $0.58, Gentex's revenue of $651.3 million fell short of estimates and saw a 1% year-over-year decline.